• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用机器学习特征重要性预测新生血管性年龄相关性黄斑变性对抗血管内皮生长因子治疗早期反应有限的因素

Predictors of limited early response to anti-vascular endothelial growth factor therapy in neovascular age-related macular degeneration with machine learning feature importance.

作者信息

Perkins Scott W, Wu Anna K, Singh Rishi P

机构信息

Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio, USA.

Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.

出版信息

Saudi J Ophthalmol. 2022 Oct 14;36(3):315-321. doi: 10.4103/sjopt.sjopt_73_22. eCollection 2022 Jul-Sep.

DOI:10.4103/sjopt.sjopt_73_22
PMID:36276255
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9583356/
Abstract

PURPOSE

Patients with neovascular age-related macular degeneration (nAMD) have varying responses to anti-vascular endothelial growth factor injections. Limited early response (LER) after three monthly loading doses is associated with poor long-term vision outcomes. This study predicts LER in nAMD and uses feature importance analysis to explain how baseline variables influence predicted LER risk.

METHODS

Baseline age, best visual acuity (BVA), central subfield thickness (CST), and baseline and 3 months intraretinal fluid (IRF) and subretinal fluid (SRF) for 286 eyes were collected in a retrospective clinical chart review. At month 3, LER was defined as the presence of fluid, while early response (ER) was the absence thereof. Decision tree classification and feature importance methods determined the influence of baseline age, BVA, CST, IRF, and SRF, on predicted LER risk.

RESULTS

One hundred and sixty-seven eyes were LERs and 119 were ERs. The algorithm achieved area under the curve = 0.66 in predicting LER. Baseline SRF was most important for predicting LER while age, BVA, CST, and IRF were somewhat less important. Nonlinear trends were observed between baseline variables and predicted LER risk. Zones of increased predicted LER risk were identified, including age <74 years, and CST <290 or >350 μm, IRF >750 nL, and SRF >150 nL.

CONCLUSION

These findings explain baseline variable importance for predicting LER and show SRF to be the most important. The nonlinear impact of baseline variables on predicted risk is shown, increasing understanding of LER and aiding clinicians in assessing personalized LER risk.

摘要

目的

新生血管性年龄相关性黄斑变性(nAMD)患者对抗血管内皮生长因子注射的反应各不相同。在接受三个月的负荷剂量注射后出现有限早期反应(LER)与长期视力不佳相关。本研究预测nAMD中的LER,并使用特征重要性分析来解释基线变量如何影响预测的LER风险。

方法

通过回顾性临床病历审查,收集了286只眼睛的基线年龄、最佳视力(BVA)、中心子野厚度(CST)以及基线和3个月时的视网膜内液(IRF)和视网膜下液(SRF)。在第3个月时,LER定义为存在液体,而早期反应(ER)则为不存在液体。决策树分类和特征重要性方法确定了基线年龄、BVA、CST、IRF和SRF对预测的LER风险的影响。

结果

167只眼睛为LER,119只为ER。该算法在预测LER时的曲线下面积 = 0.66。基线SRF对预测LER最为重要,而年龄、BVA、CST和IRF的重要性稍低。观察到基线变量与预测的LER风险之间存在非线性趋势。确定了预测LER风险增加的区域,包括年龄<74岁、CST<290或>350μm、IRF>750 nL和SRF>150 nL。

结论

这些发现解释了基线变量对预测LER的重要性,并表明SRF是最重要的。显示了基线变量对预测风险的非线性影响,增加了对LER的理解,并有助于临床医生评估个性化的LER风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de60/9583356/50eb81986e1d/SJO-36-315-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de60/9583356/107538fef66b/SJO-36-315-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de60/9583356/7f38be249d96/SJO-36-315-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de60/9583356/486c31c75778/SJO-36-315-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de60/9583356/50eb81986e1d/SJO-36-315-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de60/9583356/107538fef66b/SJO-36-315-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de60/9583356/7f38be249d96/SJO-36-315-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de60/9583356/486c31c75778/SJO-36-315-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de60/9583356/50eb81986e1d/SJO-36-315-g004.jpg

相似文献

1
Predictors of limited early response to anti-vascular endothelial growth factor therapy in neovascular age-related macular degeneration with machine learning feature importance.利用机器学习特征重要性预测新生血管性年龄相关性黄斑变性对抗血管内皮生长因子治疗早期反应有限的因素
Saudi J Ophthalmol. 2022 Oct 14;36(3):315-321. doi: 10.4103/sjopt.sjopt_73_22. eCollection 2022 Jul-Sep.
2
Correlation of limited-early-response status with 12-month CST, BVA, and machine learning-quantified retinal fluid in diabetic macular oedema in routine clinical practice.在常规临床实践中,有限早期应答状态与 12 个月 CST、BVA 和机器学习量化视网膜液在糖尿病性黄斑水肿中的相关性。
Eye (Lond). 2024 Oct;38(14):2805-2812. doi: 10.1038/s41433-024-03172-4. Epub 2024 Jun 18.
3
Characterizing Early Residual Fluid in Neovascular Age-Related Macular Degeneration using Machine Learning in Routine Clinical Practice.使用机器学习在常规临床实践中对新生血管性年龄相关性黄斑变性的早期残余液进行特征描述。
Ophthalmol Retina. 2022 Dec;6(12):1154-1164. doi: 10.1016/j.oret.2022.06.006. Epub 2022 Jun 25.
4
Impact of Intra- and Subretinal Fluid on Vision Based on Volume Quantification in the HARBOR Trial.基于 HARBOR 试验中体积定量的眼内和视网膜下液对视功能的影响。
Ophthalmol Retina. 2022 Apr;6(4):291-297. doi: 10.1016/j.oret.2021.12.007. Epub 2021 Dec 16.
5
Role of intraretinal and subretinal fluid on clinical and anatomical outcomes in patients with neovascular age-related macular degeneration treated with bimonthly, treat-and-extend and as-needed ranibizumab in the In-Eye study.在 In-Eye 研究中,接受每月两次、按需治疗和按需治疗的 ranibizumab 治疗的新生血管性年龄相关性黄斑变性患者中,视网膜内和视网膜下液对临床和解剖结果的作用。
Acta Ophthalmol. 2021 Dec;99(8):861-870. doi: 10.1111/aos.14786. Epub 2021 Mar 15.
6
Quantification of Fluid Resolution and Visual Acuity Gain in Patients With Diabetic Macular Edema Using Deep Learning: A Post Hoc Analysis of a Randomized Clinical Trial.利用深度学习技术对糖尿病性黄斑水肿患者的液体积聚消退和视力提高程度进行定量评估:一项随机临床试验的事后分析。
JAMA Ophthalmol. 2020 Sep 1;138(9):945-953. doi: 10.1001/jamaophthalmol.2020.2457.
7
Effect of Residual Retinal Fluid on Visual Function in Ranibizumab-Treated Neovascular Age-Related Macular Degeneration.雷珠单抗治疗的新生血管性年龄相关性黄斑变性中残余视网膜下液对视觉功能的影响。
Am J Ophthalmol. 2022 Jan;233:8-17. doi: 10.1016/j.ajo.2021.06.029. Epub 2021 Jul 18.
8
Analyses of the effects of persistent subretinal fluid on visual/anatomic outcomes according to the type of macular neovascularization during the relaxed treat-and-extend protocol in age-related macular degeneration patients.根据年龄相关性黄斑变性患者放松治疗和扩展方案中黄斑新生血管的类型,分析持续性视网膜下液对视觉/解剖结果的影响。
BMC Ophthalmol. 2021 Aug 10;21(1):294. doi: 10.1186/s12886-021-02063-6.
9
The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration--a phase IV randomised clinical trial with ranibizumab: the FLUID study.视网膜下液在新生血管性年龄相关性黄斑变性患者治疗结局判定中的作用——一项雷珠单抗的IV期随机临床试验:FLUID研究
BMC Ophthalmol. 2016 Mar 24;16:31. doi: 10.1186/s12886-016-0207-3.
10
Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab.阿柏西普治疗对贝伐单抗和雷珠单抗耐药的渗出性年龄相关性黄斑变性
Int J Retina Vitreous. 2021 Apr 1;7(1):26. doi: 10.1186/s40942-021-00299-4.

本文引用的文献

1
Characterizing Early Residual Fluid in Neovascular Age-Related Macular Degeneration using Machine Learning in Routine Clinical Practice.使用机器学习在常规临床实践中对新生血管性年龄相关性黄斑变性的早期残余液进行特征描述。
Ophthalmol Retina. 2022 Dec;6(12):1154-1164. doi: 10.1016/j.oret.2022.06.006. Epub 2022 Jun 25.
2
Impact of Intra- and Subretinal Fluid on Vision Based on Volume Quantification in the HARBOR Trial.基于 HARBOR 试验中体积定量的眼内和视网膜下液对视功能的影响。
Ophthalmol Retina. 2022 Apr;6(4):291-297. doi: 10.1016/j.oret.2021.12.007. Epub 2021 Dec 16.
3
Early Residual Fluid-Free Status and Long-Term BCVA Outcomes: A Treatment Agnostic, Post Hoc Analysis of Pooled HAWK and HARRIER Data.
早期无残余液状态与长期 BCVA 结局:HAWK 和 HARRIER 数据的汇总、治疗不可知论者的事后分析。
Am J Ophthalmol. 2022 Apr;236:12-19. doi: 10.1016/j.ajo.2021.10.017. Epub 2021 Oct 22.
4
Effect of Residual Retinal Fluid on Visual Function in Ranibizumab-Treated Neovascular Age-Related Macular Degeneration.雷珠单抗治疗的新生血管性年龄相关性黄斑变性中残余视网膜下液对视觉功能的影响。
Am J Ophthalmol. 2022 Jan;233:8-17. doi: 10.1016/j.ajo.2021.06.029. Epub 2021 Jul 18.
5
Relationship between retinal fluid and visual acuity in patients with exudative age-related macular degeneration treated with intravitreal aflibercept using a treat-and-extend regimen: subgroup and post-hoc analyses from the ALTAIR study.玻璃体内注射阿柏西普治疗渗出型年龄相关性黄斑变性患者的眼内液与视力的关系:来自 ALTAIR 研究的亚组和事后分析。
Graefes Arch Clin Exp Ophthalmol. 2021 Dec;259(12):3637-3647. doi: 10.1007/s00417-021-05293-y. Epub 2021 Jul 20.
6
Predominantly Persistent Subretinal Fluid in the Comparison of Age-Related Macular Degeneration Treatments Trials.年龄相关性黄斑变性治疗试验中的主要持续性视网膜下液。
Ophthalmol Retina. 2021 Oct;5(10):962-974. doi: 10.1016/j.oret.2021.06.003. Epub 2021 Jun 11.
7
Machine Learning Can Predict Anti-VEGF Treatment Demand in a Treat-and-Extend Regimen for Patients with Neovascular AMD, DME, and RVO Associated Macular Edema.机器学习可预测接受抗血管内皮生长因子治疗及延长治疗方案的新生血管性年龄相关性黄斑变性、糖尿病性黄斑水肿和视网膜静脉阻塞相关黄斑水肿患者的抗 VEGF 药物治疗需求。
Ophthalmol Retina. 2021 Jul;5(7):604-624. doi: 10.1016/j.oret.2021.05.002. Epub 2021 May 8.
8
Predicting eyes at risk for rapid glaucoma progression based on an initial visual field test using machine learning.基于机器学习的初始视野测试预测快速青光眼进展风险的眼睛。
PLoS One. 2021 Apr 16;16(4):e0249856. doi: 10.1371/journal.pone.0249856. eCollection 2021.
9
Predicting Progression to Advanced Age-Related Macular Degeneration from Clinical, Genetic, and Lifestyle Factors Using Machine Learning.基于机器学习,利用临床、遗传和生活方式因素预测晚期年龄相关性黄斑变性的进展。
Ophthalmology. 2021 Apr;128(4):587-597. doi: 10.1016/j.ophtha.2020.08.031. Epub 2020 Sep 2.
10
Retinal Specialist versus Artificial Intelligence Detection of Retinal Fluid from OCT: Age-Related Eye Disease Study 2: 10-Year Follow-On Study.视网膜专家与人工智能检测 OCT 中的视网膜液:年龄相关性眼病研究 2:10 年随访研究。
Ophthalmology. 2021 Jan;128(1):100-109. doi: 10.1016/j.ophtha.2020.06.038. Epub 2020 Jun 27.